Round Hill Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $518K | Hold |
3,392
| – | – | 0.34% | 48 |
|
|
2025
Q4 | $468K | Hold |
3,392
| – | – | 0.29% | 51 |
|
|
2025
Q3 | $435K | Hold |
3,392
| – | – | 0.29% | 51 |
|
|
2025
Q2 | $410K | Hold |
3,392
| – | – | 0.28% | 51 |
|
|
2025
Q1 | $378K | Hold |
3,392
| – | – | 0.27% | 52 |
|
|
2024
Q4 | $330K | Hold |
3,392
| – | – | 0.23% | 55 |
|
|
2024
Q3 | $390K | Hold |
3,392
| – | – | 0.26% | 51 |
|
|
2024
Q2 | $361K | Hold |
3,392
| – | – | 0.23% | 53 |
|
|
2024
Q1 | $328K | Hold |
3,392
| – | – | 0.2% | 51 |
|
|
2023
Q4 | $342K | Hold |
3,392
| – | – | 0.22% | 50 |
|
|
2023
Q3 | $346K | Sell |
3,392
-150
| -4% | -$15.2K | 0.23% | 52 |
|
|
2023
Q2 | $357K | Hold |
3,542
| – | – | 0.22% | 55 |
|
|
2023
Q1 | $326K | Hold |
3,542
| – | – | 0.2% | 54 |
|
|
2022
Q4 | $321K | Sell |
3,542
-100
| -3% | -$8.42K | 0.2% | 53 |
|
|
2022
Q3 | $277K | Hold |
3,642
| – | – | 0.19% | 55 |
|
|
2022
Q2 | $308K | Hold |
3,642
| – | – | 0.19% | 56 |
|
|
2022
Q1 | $320K | Hold |
3,642
| – | – | 0.17% | 56 |
|
|
2021
Q4 | $319K | Hold |
3,642
| – | – | 0.16% | 53 |
|
|
2021
Q3 | $298K | Hold |
3,642
| – | – | 0.15% | 56 |
|
|
2021
Q2 | $332K | Hold |
3,642
| – | – | 0.16% | 54 |
|
|
2021
Q1 | $311K | Hold |
3,642
| – | – | 0.16% | 56 |
|
|
2020
Q4 | $344K | Hold |
3,642
| – | – | 0.19% | 54 |
|
|
2020
Q3 | $317K | Sell |
3,642
-200
| -5% | -$17.3K | 0.19% | 53 |
|
|
2020
Q2 | $336K | Hold |
3,842
| – | – | 0.21% | 49 |
|
|
2020
Q1 | $317K | Hold |
3,842
| – | – | 0.22% | 50 |
|
|
2019
Q4 | $364K | Sell |
3,842
-8
| -0.2% | -$718 | 0.2% | 48 |
|
|
2019
Q3 | $335K | Hold |
3,850
| – | – | 0.19% | 49 |
|
|
2019
Q2 | $352K | Sell |
3,850
-447
| -10% | -$37.8K | 0.2% | 48 |
|
|
2019
Q1 | $370K | Hold |
4,297
| – | – | 0.22% | 49 |
|
|
2018
Q4 | $330K | Hold |
4,297
| – | – | 0.22% | 49 |
|
|
2018
Q3 | $332K | Buy |
4,297
+84
| +2% | +$6.21K | 0.2% | 50 |
|
|
2018
Q2 | $291K | Sell |
4,213
-84
| -2% | -$5.8K | 0.18% | 51 |
|
|
2018
Q1 | $311K | Sell |
4,297
-279
| -6% | -$21.2K | 0.19% | 52 |
|
|
2017
Q4 | $344K | Hold |
4,576
| – | – | 0.2% | 51 |
|
|
2017
Q3 | $352K | Hold |
4,576
| – | – | 0.2% | 51 |
|
|
2017
Q2 | $342K | Hold |
4,576
| – | – | 0.2% | 50 |
|
|
2017
Q1 | $305K | Hold |
4,576
| – | – | 0.17% | 54 |
|
|
2016
Q4 | $299K | Buy |
+4,576
| New | +$297K | 0.18% | 58 |
|
Other funds holding NVS
Round Hill Asset Management's NVS Position: Q1 2026 in Review
Round Hill Asset Management held its Novartis (NVS) position steady in Q1 2026 at 3,392 shares worth $518K. The position accounts for 0.34% of the portfolio, ranked #48.
Round Hill Asset Management first reported a position in NVS in Q4 2016 and has held it in 38 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Round Hill Asset Management held 3,392 shares of Novartis worth $518K as of Q1 2026.
- Round Hill Asset Management left its Novartis share count unchanged in Q1 2026.
- Novartis made up 0.34% of Round Hill Asset Management's portfolio in Q1 2026, its #48 holding.
- Round Hill Asset Management first reported a position in Novartis in Q4 2016 and has held it in 38 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Round Hill Asset Management's 13F filing for Q1 2026, filed 14 May 2026.